Tracheal Replacements: Part 1
Kucera, Kristin A.*; Doss, Amy E.*; Dunn, Sarah S.*; Clemson, Lindsey A.†; Zwischenberger, Joseph B.*
From the *Department of Surgery, University of Texas Medical Branch, Galveston, Texas; †Department of Otolaryngology, Emory University, Atlanta, Georgia, U.S.A.
Submitted for consideration October 2006; accepted for publication in revised form March 2007.
Reprint Requests: Joseph B. Zwischenberger, MD, Department of Surgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, U.S.A.
In this review, we summarize the history of tracheal reconstruction and replacement as well as progress in current tracheal substitutes. In Part 1, we cover the historical highlights of grafts, flaps, tube construction, and tissue transplants and address the progress made in tracheal stenting as a means of temporary tracheal support. This is followed in Part 2 by an analysis of solid and porous tracheal prostheses in experimental and clinical trials. We conclude Part 2 with a summary of recent efforts toward generating a bioengineered trachea. Finally, we provide an algorithm on the spectrum of options available for tracheal replacement.
The need for a prosthetic tracheal replacement is constantly modified by improved surgical techniques for tracheal resection with primary reconstruction. Recent knowledge of tracheal blood supply, mobilization and anastomotic techniques, tolerance of tension, and local tissue reinforcement, as well as postural effects, impacts significantly on the lengths of primary resection/reconstruction. Extensive lesions, such as neoplasms or stenosis, that are longer than half the trachea in adults, or one third the trachea in children, may require prostheses. The spectrum of tracheal replacements ranges from autologous tissue flaps and patches to synthetic stents and prostheses to tissue engineered scaffolding. The goals for a tracheal replacement, as proposed by Belsey1 50 years ago, are (1) a laterally rigid but longitudinally flexible tube, and (2) a surface of ciliated respiratory epithelium. Patients can, however, clear secretions by cough regardless of the conduit surface, decreasing the necessity of the second requirement.
As for artificial prosthetics, as with all artificial organs, the foreign materials should be biocompatible, nontoxic, nonimmunogenic, and noncarcinogenic.2,3 Ideally, these materials should provide or facilitate epithelial resurfacing and not dislocate or erode over time. Tracheal replacements should avoid stenosis and accumulation of secretions and resist bacterial colonization.
To date, no evidence-based clinical trials or clearly superior technology for tracheal replacement has emerged. This review will therefore discuss the techniques and current progress in tracheal replacement and will identify future challenges in the development of tracheal substitutes. In Part 1, we cover the historical highlights of grafts, flaps, tube construction, and tissue transplants and address the progress made in tracheal stenting as a means of temporary tracheal support. This is followed in Part 2 by an analysis of solid and porous tracheal prostheses in experimental and clinical trials as well as a summary of recent efforts toward generating a bioengineered trachea. Finally, we provide an algorithm (Figure 1) on the spectrum of options available for tracheal replacement.
The optimal method of tracheal reconstruction for a defect <50% of the tracheal length is by circumferential resection and end-to-end anastomosis.4 To facilitate tensionless closure of the tracheal defect, cervical neck flexion can add up to 6 cm. Other methods to add length include extreme transcervical mobilization of the trachea and mainstem bronchi and the suprahyoid laryngeal release. Both provide 1.0–2.0 cm while minimizing the swallowing difficulties of other release procedures. Transthoracic mobilization of the right hilus with division of the pulmonary ligament, intrapericardial dissection of pulmonary vessels, and division of intracartilaginous tracheal ligament allows an additional 3–4 cm length. Combined cervicomediastinal approach may be required for stenosis >5–6 cm, if stenosis is within the thoracic inlet, or if adequate mobilization is not achieved with a cervical approach.1,5–7 The length of resectable trachea varies with age, posture, body habitus, and degree of tracheal pathology.
The Z-plasty technique from plastic surgery has been utilized in noncancerous long tracheal lesions to extend the remaining trachea without breaking epithelial continuity. This technique reduces tension and provides an irregular, but nonetheless continuous, sheet of ciliated epithelium for evacuation of secretions. Foreign material or tissue grafts are used to cover the window defect; however, problems with infection of the patches has limited the use of Z-plasty clinically.8
Autogenous Grafts With and Without Foreign Material
Tracheal reconstruction, for which primary end-to-end anastomosis cannot be performed, remains an unsolved clinical problem. So far, tracheal replacement approaches have included the use of autologous tissue, autografts, allografts, prosthetic materials, and tissue-engineered trachea, singly or in combination. Unfortunately, limited success has been achieved experimentally and clinically due to anastomotic stenosis, immunologic rejection, local infections, prosthetic dislocation, and material failure.
Various outcomes from using autogenous tissue as patches or in tubular form such as fascia lata,9–12 tracheal wall,9 pericardium,13–15 periosteum with omental wrap,16,17 bone strips with fibrocollagen,18 periosteal patch applied to staggered intercartilaginous relaxing incisions,8 buccal mucosa and auricular cartilage,19 jejunal patches with microvascular reconstruction,20 rib and ear perichondrium,21 nasal cartilage with attached mucosa,22 bronchial patch,23 epidermis,24,25 free fascial graft,26 auricular27 and costal28 cartilage, indicate that small defects can be successfully treated with graft repairs. More recent clinical examples use autogenous tissue such as bronchial patches, dermal grafts, pericardium, and aortic grafts (Table 1). New experimental studies and case reports causing excitement because of their success include Martinod's29,30 use of a thoracic aortic patch with temporary stenting in sheep and his finding of aortic tissue metaplasia into well-differentiated tracheal tissue, including a mucociliary epithelium and regular rings of newly formed cartilage, and Dodge-Khatami's31 use of a carotid artery patch in children both point to future discoveries. Artificial materials used to maintain a rigid wall and support autogenous tissue grafts include: diced cartilage against wire mesh and glass cylinders,32 dermal grafts with wire,33 fascia with tantalum mesh,5,34 tantalum tube,35 Marlex mesh, pericardium with Marlex,13 cartilage and perichondrial strips with silicone stents,36 costal cartilage with polyethylene stents,37 dura mater with wire,38 bladder mucosa with silicone elastomer or polyurethane stents,39,40 fascia lata with coils of steel wire,1,41 fascial flap with polytetrafluoroethylene.42 These foreign materials may be used to prevent collapse of the lumen while various autogenous tissue grafts grow across the partial defects. Associated complications with foreign material were mostly related to lack of biocompatibility and included local infection, anastomotic dehiscence, vascular erosion, granulomatous lesions, and stenosis (Table 2).
Tracheal transplantation is also being explored but the need for lifelong immunosuppression may inadvertently interfere with tumor disease. Recent experimental studies reported a diminished need for immunosuppression after implantation of grafts pretreated with cryopreservation9,43 or irradiation.32
Autologous tissue reconstruction is always preferable to alloplastic materials. Although tissue grafts can successfully regenerate partial tracheal defects, circumferential or large defects require blood supply and mucosal lining for expectoration. The advantages of flap tissue over graft materials are the independence of its blood supply and its reliability in terms of wound healing. Flap surgery can be done to irradiated or heavily scarred areas, where grafting techniques have little chance to be successful.
Local, regional, and distant free flaps have been reported for experimental tracheal reconstruction, and usually some skeletal element is added. Experiments in vascularized autogenous tissue repair include local skin flaps,44 pedicled intercostal muscle patch,45 pedicled periosteum,16 pedicled bronchus,46 rib and pleural transfer with microvascular anastomosis.47 Tissues from nearly every part of the body have been utilized in an attempt to find the best tissue for tracheal replacement. Examples include a successful multistage procedure using buccal mucosa in beagles,44 omental grafts connected to the esophagus requiring stent placement,48 and mucochondrial composite using vascularization from the thyroid gland.49 A stented tubed radial forearm flap failed with exuberant granulation tissue and stricture formation, but allograft tracheoplasty with radial forearm free flap resulted in nonstenotic trachea.42,50,51 Although experimental autogenous tissue flaps have successfully supported short segments of tracheal reconstruction, the lengthy multistage procedure creates a process not feasible in the situation of cancer treatment.
Clinically, cutaneous chondromucosal forearm tubular flaps, compound tracheal segments vascularized by sternocleidomastoid muscle, deltopectoral flap with costal cartilage and palatal mucosal grafts, and pectoralis major myocutaneous flap with costal cartilage all allowed nonstenotic successful airways; however, all procedures require lengthy multiple stages (Table 3). Yu et al.52 used a radial forearm free flap with polymex mesh and hemishield vascular graft creating a nonstented airway with normal swallowing and voice. Although vascularized autogenous tissue flaps have overall produced successful results with patent, nonstenotic airway, the limiting factor in nearly every procedure remains the complexity and multistage requirement limiting the practicality of the procedure.
Autogenous Tube Construction
The cervical trachea has been experimentally created by formation of a cutaneous trough supported by cartilage rings with staged closure of the trough assisted by tubed pedicle flap from the upper chest wall.34,53,54 Other animal experiments include microvascular jejunal transfer with a cartilage skeleton, series of bilateral hemi rings of cartilage carved from costal arch vascularized by pectoral flap, muscle and flaps stiffened with cartilage and lined with skin around a stent, and rib perichondrium around silicone rods. All procedures resulted in difficult or negative outcomes.34,55–59 Clinically, tube construction has been successfully completed by Edgerton, Serrano, and Zhao34,55,60; however, all procedures were multistage difficult procedures used as a last resort (Table 4).
The first report of tracheal autografts in 1918 reported successful transfer of 3–9 segments in half of the subjects. Orthotopic transplantation of tracheal tissue was most often unsuccessful, because blood supply to the transplanted tissue was too slow to prevent necrosis or stenosis. In autografts of very short segments the animals survived; however, the cartilage was absorbed and converted to fibrous tissue.61 Longer segments resulted in dissolution, stenosis, and obstruction due to loss of blood supply.62 Multiple experiments concluded survival with devascularized autografts is poor with only minimal success using short segments.62–65 Tracheal allografts mostly met with failure due to rejection.65–68 However, even with immunosuppression the allografts failed with abundance of fibrous tissue.9,34,62,63,69 Very short grafts resulted in minor fibrous tissue to complete fibrous stenosis.4,62,65,70–72 Although allografts of partial tracheal wall prevented lumen obstruction, even these grafts were replaced by flaccid scars.73 Studies by Beigel et al.66 concluded tracheal transplants carry antigens and have immunogenic action from the donor; Bujia et al.67 supported these results reporting the mucosa of the human trachea is the major antigenic source. Because of these failures, attempts were made to preserve the tissue and remove antigenic sources. Experiments involved partly de-epithelializing, merthiolate-treating, and cold-preserving canine allografts. Preserving solutions include Tyrode's solution, 4% formaldehyde, alcohol, saline, or lyophilization at −4°C.2,32,65,74–77 The results from these attempts were uniform failures with fibrosis, stenosis, or necrosis the usual outcome.
Autografts can be directly vascularized by anastomoses or with pedicled flaps. Early attempts at tracheal allotransplantation achieved patent airways, and although omental transplants promoted early revascularization, experiments to minimize postsurgical complications continued (Table 5).123–125 Indirect vascularization using omentopexy could sustain short tracheal segments and promoted quicker revascularization, but the omentum is not sufficient to support long tracheal grafts nor chondrocytes.78–83 Yokomise et al.84 prevented central graft necrosis by introducing an autograft split in the middle by an omental circumferential insertion. The grafts revascularized without stenosis or necrosis. Murai et al.85 removed the cartilage rings before transplantation to increase omental contact resulting in improved blood supply and reepithelialization. Fresh allografts with omental revascularization without immunosuppression failed due to rejection81,83,86–89; however, cryopreserved allografts with omental flap revascularization survived without immunosuppression.84,86,87 Cryopreservation inhibits allogenicity while structural integrity appears to be maintained. Cryopreservation of allografts reduces acute rejection and permits early revascularization, but chronic rejection leads to vascular occlusion and atrophy.86,89,90 Direct revascularization of grafts concluded mixed results. Composite thyrotracheal graft vascularized by thyroid artery anastomosed to the common carotid without immunosuppression preserved cartilage, but tracheal soft tissue necrosed. All tissues survived with immunosuppression from cyclosporine and hydrocortisone.91 Daly et al.92 anastomosed the largest bronchial artery in a patch of descending aorta to the recipient left internal thoracic artery with excellent airway healing without dehiscence or granulation tissue of trachea.
Although the idea for airway stenting can be dated back to the 1800s,93 the technology to use stenting for airway lesions (obstruction, stenosis, etc.) emerged only in the last 50 years. Harkins used a metal alloy tube to treat a patient with benign tracheal stenosis in 1952,94 and in the 1960s, Montgomery developed a silicon T-shaped prosthesis, the Montgomery T-tube, as a tracheal stent.95 The major problem was finding a material that would not lead to infection or foreign body reaction and could be placed with minimal trauma and complications. The ideal stent needs to fit securely in the airway lumen without requiring external fixation and without causing mucosal injury.96 Satisfactory expansion of the stricture must occur regardless of the origin or the forces causing extrinsic compression, be resistant to extrinsic compression, and allow manipulation in case of obstruction from tumor overgrowth or secretions.96,97 The formation of granulation tissue secondary to airway inflammation should be minimal, and surrounding vascular and cartilaginous structures should not be damaged.
Endotracheal/bronchial stenting may open large airways severely narrowed or obstructed due to a tumor mass, when the patient is not a candidate for surgical treatment, primary radiation, or chemotherapy, or when those therapies are not likely to be effective alone.96 Other tracheobronchial disorders requiring stents include complications from tracheostomy, postintubation injuries (such as subglottic stenosis), benign tracheal stenosis (for nonsurgical candidates, patients refractory to bronchoscopic resection or dilatation, or pending response to systemic therapy or surgical resection), tracheobronchomalacia, anastomotic strictures after lung and heart-lung transplantation, or tracheo- or broncho-esophageal fistula.97,98
There are two main types of stents in use today—silicone tube stents and expandable metallic stents. We will primarily focus on stents which have the potential to serve as tracheal replacements.
Silicone Tube Stents
The Montgomery T-tube, the first of the silicone stents, remains important in the treatment of subglottic stenosis or obstruction. It serves as both an upper tracheal stent and tracheostomy tube and is inserted through a tracheostomy stoma.96,98 Many versions of the Montgomery T-tube have been developed over the years, including one by Westaby et al.99 with a long distal branch that bifurcates at the carina.96,98 An endoscopically placed, modified Silastic T-tube stent was used by Cooper et al.100 in patients with malignant tracheobronchial obstruction. The horizontal limb was pulled out through a tracheostomy stoma much like the Montgomery T-tube.98
The Dumon stent (Bryan Corp, Woburn, MA) is a silicone tube stent that has external studs at regular intervals to prevent problems with stent migration and dislodgement. These stents have proven to have excellent clinical outcomes when placed in lower trachea or bronchi.101,102 The Dynamic stent (Rüsch, AG Kernan, Germany) is a silicone Y-stent with a long tracheal and left main bronchial limb, short right bronchial limb, metallic ring-reinforced anterolateral walls, and a collapsible posterior wall that mimics the dynamics of the membranous trachea during respiration.103
The main advantages of using silicone stents are their removability, unreactivity, adjustability, resistance to tumor ingrowth, and minimal granulation tissue formation.98,104 Silicone stents are also easily customized to fit the airway anatomy of any patient and have a defined, fixed diameter that prevents uncontrolled expansion.104 Limitations of using silicone stents include difficult placement; tendency to dislodge, distort, or migrate resulting in need for revision or replacement; lack of tissue ingrowth and epithelization; obstruction from secretion accumulation; and the need for rigid bronchoscopy and general anesthesia for placement.98,104 Also, these stents have a lower inner-to-outer diameter ratio compared with metallic stents, which contributes to stent obstruction from secretions. See Table 6 for specific details.98
Expandable Metallic Stents
The successful use of expandable metallic stents in the vascular and biliary systems has led to their use in the treatment of benign and malignant airway stenoses.98 The Gianturco stent, a first-generation expandable metallic stent, allows delivery via a catheter into vascular or airway stenoses.105,106 Available in fixed lengths (2 or 2.5 cm), tandem stents have also been constructed. The Palmaz stent is a fixed-diameter, balloon-expandable, stainless steel wire mesh tubular stent. Because this stent does not exhibit intrinsic radial force, it is positioned and seated by balloon expansion, and once expanded does not exert continual expanding pressure on the airway; therefore, it theoretically has less risk of hyperexpansion and perforation.98,104
The second generation of expandable metallic stents began with the development of the Wallstent, also known as the Schneider prosthesis. The Wallstent is a self-expandable tubular mesh stent made of braided cobalt-based super alloy monofilaments coated with silicone. It is loaded in a delivery catheter, inserted with flexible fiberoptic bronchoscope under fluoroscopic guidance, and then expands to the preset diameter.98 Commonly used in Europe for airway stenoses, the Wallstent has excellent flexibility and conformance to the patient's airway, is easily adaptable, and effectively treats pure extrinsic compression and esophagobronchial fistulas.96 However, the Wallstent has significant problems with tumor and granulation tissue ingrowth that often results in obstruction. A newer version of the Wallstent, the Permalume, is covered by a thin layer of silicone rubber all except the proximal and distal 5 mm, to prevent tumor or granulation tissue ingrowth through the stent. The Wallgraft has the same construction as the Wallstent and Permalume except it is completely covered by polyethylene.104
The latest version of the Wallstent is the Ultraflex stent, a self-expandable stent made of woven single strand nitinol (nickel-titanium alloy) that allows for easier endoscopic retrieval. Uniquely, the nickel-titanium alloy has “shape-memory,” meaning that at low temperatures it deforms plastically (martensitic state) and at high temperatures it regains its original shape (austenitic state).107 For placement of these stents, a guidewire is inserted via rigid bronchoscope and positioned fluoroscopically under general anesthesia. The stents are inserted on a loaded delivery catheter that is advanced over the guidewire until it is radiographically aligned with previously placed skin markers identifying the limits of the lesion.108,109
The smooth and studded Polyflex stents are newly available options for expandable metallic stents. Polyflex stents are self-expandable silicone-covered polyester wire mesh stents designed to prevent tumor ingrowth via the internal silicone coating.
Advantages of the more permanent expandable metallic stents over silicone tube stents include easier delivery and placement via flexible bronchoscope and fluoroscopic guidance under local anesthesia, higher internal-to-external diameter ratio, less obstruction from secretions, improved stability, decreased migration, and ability to accommodate to multiple tracheal dimensions.98,104 These types of stents are also particularly useful in patients with intense extrinsic compression or large areas of obstruction or stenosis. Uncovered metallic stents, theoretically, have improved epithelization and incorporation into the surrounding tracheal tissue.104 Covered stents have the advantage of decreased tumor or granulation tissue ingrowth and improved removability. However, the uncovered bare metal ends still have the potential for tumor ingrowth or granulation tissue.104
The permanence and, therefore, decreased adjustability and removability are among the primary disadvantages to using expandable metallic stents. This is particularly problematic for patients with benign tracheal stenosis or when tumor ingrowth or granulation tissue causes stent obstruction necessitating repeat debridement or re-stenting.98,104 The need for fluoroscopy and potential for erosion into surrounding structures with possible bronchovascular fistulas are less favorable aspects of expandable metallic stents.104 See Table 7 for specific details of these stents.
The management of tracheal defects for which primary end-to-end anastomosis cannot be performed remains a clinical challenge. To date, the use of tissue flaps, autografts, allografts, prosthetic materials, stents, or a combination of these methods has met with limited clinical significance due to a multitude of complications. We have constructed an algorithm to show the extent of the current and potential options available for tracheal replacement (Figure 1). Fortunately, the emergence of tissue engineering has prompted exploration into tracheal substitutes that may provide more successful replacement options in the near future.
1. Belsey R: Resection and reconstruction of the intrathoracic trachea. Br J Surg
38: 200–205, 1950.
2. Jackson TL, O'Brien EJ, Tuttle W, Meyer J: The experimental use of homogenous tracheal transplants in the restoration of continuity of the tracheobronchial tree. J Thorac Surg
20: 598–612; passim, 1950.
3. Scherer MA, Ascherl R, Geissdorfer K, et al
: Experimental bioprosthetic reconstruction of the trachea. Arch Otorhinolaryngol
243: 215–223, 1986.
4. Ferguson DJ, Wild JJ, Wangensteen OH: Experimental resection of the trachea. Surgery
28: 597–619, 1950.
5. Rob CG, Bateman GH: Reconstruction of the trachea and cervical oesophagus; preliminary report. Br J Surg
37: 202–205, illust, 1949.
6. Grillo HC, Dignan EF, Miura T: Extensive resection and reconstruction of mediastinal trachea without prosthesis or graft: an anatomical study in man. J Thorac Cardiovasc Surg
48: 741–749, 1964.
7. Dedo HH, Fishman NH: Laryngeal release and sleeve resection for tracheal stenosis. Ann Otol Rhinol Laryngol
78: 285–296, 1969.
8. Narodick BG, Worman LW, Pemberton AH: Relaxation technique for tracheal reconstruction. Ann Thorac Surg
24: 190–196, 1965.
9. Daniel RJ, Taliaferro RM, Schaffarzick WR: Experimental studies on the repair of wounds and defects of the trachea and bronchi. Dis Chest
17: 426–441, 1950.
10. Swift EA, Grindlay JH, Clagett OT: The repair of tracheal defects with fascia and tantalum mesh: an experimental study. J Thorac Surg
24: 482–492, 1952.
11. Davis J: The transplantation of free flaps of fascia. An experimental study. Ann Surg
54: 734–748, 1911.
12. Taffel M: The repair of tracheal and bronchial defects with free fascia grafts. Surgery
8: 56–71, 1940.
13. Bryant LR: Replacement of tracheobronchial defects with autogenous pericardium. J Thorac Cardiovasc Surg
48: 733–740, 1964.
14. Cheng AT, Backer CL, Holinger LD, Dunham ME, Mavroudis C, Gonzalez-Crussi F: Histopathologic changes after pericardial patch tracheoplasty. Arch Otolaryngol Head Neck Surg
123: 1069–1072, 1997.
15. Idriss FS, DeLeon SY, Ilbawi MN, Gerson CR, Tucker GF, Holinger L: Tracheoplasty with pericardial patch for extensive tracheal stenosis in infants and children. J Thorac Cardiovasc Surg
88: 527–536, 1984.
16. Fonkalsrud E, Plested, WG, Mulder, DG: Tracheobronchial reconstruction with autogenous periosteum. J Thorac Cardiovasc Surg
52: 666–674, 1966.
17. Cohen RC, Filler RM, Konuma K, Bahoric A, Kent G, Smith C: A new model of tracheal stenosis and its repair with free periosteal grafts. J Thorac Cardiovasc Surg
92: 296–304, 1986.
18. Bailey BJ, Kosoy J: Observations in the development of tracheal prostheses and tracheal transplantation. Laryngoscope
80: 1553–1565, 1970.
19. Farkas LG, Farmer AW, McCain WG, Wilson WD: Replacement of a tracheal defect in the dog by a preformed composite graft. A later report. Plast Reconstr Surg
50: 238–241, 1972.
20. Jones RE, Morgan RF, Marcella KL, Mills SE, Kron IL: Tracheal reconstruction with autogenous jejunal microsurgical transfer. Ann Thorac Surg
41: 636–638, 1986.
21. Ohlsen L, Nordin U: Tracheal reconstruction with perichondrial grafts. Scand J Plast Reconstr Surg
10: 135–145, 1976.
22. Drettner B, Lindholm CE: Experimental tracheal reconstruction with composite graft from nasal septum. Acta Otolaryngol
70: 401–407, 1970.
23. MacHale SJ: A new technique for repairing the major air passages. J Thorac Cardiovasc Surg
64: 6–10, 1972.
24. Paulson DL: Plastic reconstruction of trachea and bronchi. Am Rev Tuberc
64: 477–488, 1951.
25. Abbott OA, Vanfleit WE, Roberto AE: Experiences with extending the indications for the use of tracheal and bronchial grafts. J Thorac Surg
29: 217–237, 1955.
26. Neuhof H: Fascia transplantation into visceral defects. An experimental and clinical study. Surg Gynecol Obstet
24: 383–427, 1917.
27. Caputo V, Consiglio V: The use of patient's own auricular cartilage to repair deficiency of the tracheal wall. J Thorac Cardiovasc Surg
41: 594–596, 1961.
28. Kimura K, Mukohara N, Tsugawa C, et al
: Tracheoplasty for congenital stenosis of the entire trachea. J Pediatr Surg
17: 869–871, 1982.
29. Martinod E, Agathe Seguin, Karel Pfeuty, et al: Long term evaluation of the replacement of the trachea with an autologous aortic graft. Ann Thorac Surg
75: 1572–1578, 2003.
30. Martinod E, Zakine G, Fornes P, et al
: [Metaplasia of aortic tissue into tracheal tissue. Surgical perspectives]. C R Acad Sci III
323: 455–460, 2000.
31. Dodge-Khatami A, Nijdam NC, Broekhuis E, Von Rosenstiel IA, Dahlem PG, Hazekamp MG: Carotid artery patch plasty as a last resort repair for long-segment congenital tracheal stenosis. J Thorac Cardiovasc Surg
123: 826–828, 2002.
32. Beattie EJ, Jr, Blades B, Keshishian JM: Tracheal reconstruction. J Thorac Surg
32: 707–725; discussion, 725–707, 1956.
33. Michelson E, Solomon R, Maun L, Ramirez J: Experiments in tracheal reconstruction. J Thorac Cardiovasc Surg
41: 748–759, 1961.
34. Edgerton MT, Zovickian A: Reconstruction of the trachea and infraglottic larynx. Plast Reconstr Surg
13: 167–192, 1954.
35. Matloub HS, Yu P: Engineering a composite neotrachea in a rat model. Plast Reconstr Surg
117: 123–128, 2006.
36. Eckersberger F, Moritz E, Wolner E: Circumferential tracheal replacement with costal cartilage. J Thorac Cardiovasc Surg
94: 175–180, 1987.
37. Sato R, Hasegawa I, Nakagawa J: Experimental study of tracheal reconstruction. J Thorac Surg
34: 526–538, 1957.
38. Sabas AA, Uez JB, Rojas O, Inones A, Aranguren JA: Replacement of the trachea with dura mater. Experimental work. J Thorac Cardiovasc Surg
74: 761–765, 1977.
39. Cliffton EE, Rush BF: Experimental reconstruction of the trachea with bladder mucosa. Surgery
40: 1105–1110, 1956.
40. Barker WS, Litton WB: Bladder osteogenesis aids tracheal reconstruction. Arch Otolaryngol
98: 422–425, 1973.
41. Clagett OT, Moersch HJ, Grindlay JH: Intrathoracic tracheal tumors: development of surgical technics for their removal. Ann Surg
136: 520–532, 1952.
42. Delaere P, Hierner R, Vranckx J, Hermans R: Tracheal stenosis treated with vascularized mucosa and short-term stenting. Laryngoscope
115: 1132–1134, 2005.
43. Wykoff TW: A preliminary report on segmental tracheal prosthetic replacement in dogs. Laryngoscope
83: 1072–1077, 1973.
44. Nowakowski K: Beitrag zur Tracheoplastik. Arch Klin Chir
90: 847–861, 1909.
45. Shinohara H, Yuzuriha S, Matsuo K, Kushima H, Kondoh S: Tracheal reconstruction with a prefabricated deltopectoral flap combined with costal cartilage graft and palatal mucosal graft. Ann Plast Surg
53: 278–281, 2004.
46. Akl BF, Mittelman J, Smith DE, Butler C: A new method of tracheal reconstruction. Ann Thorac Surg
36: 265–269, 1983.
47. Watson J, Donald PJ, Gourley IM, Pool R, Tyler W: Composite vascularized free-rib and pleural transfer for laryngotracheal reconstruction. Otolaryngol Head Neck Surg
91: 384–395, 1983.
48. Spaggiari L, Calabrese LS, D'Aiuto M, et al
: Successful subtotal tracheal replacement (using a skin/omental graft) for dehiscence after a resection for thyroid cancer. J Thorac Cardiovasc Surg
129: 1455–1456, 2005.
49. Zur KB, Urken ML: Vascularized hemitracheal autograft for laryngotracheal reconstruction: a new surgical technique based on the thyroid gland as a vascular carrier. Laryngoscope
113: 1494–1498, 2003.
50. Beldholm BR, Wilson MK, Gallagher RM, Caminer D, King MJ, Glanville A: Reconstruction of the trachea with a tubed radial forearm free flap. J Thorac Cardiovasc Surg
126: 545–550, 2003.
51. Genden EM, Govindaraj S: Allograft tracheoplasty technique for management of refractory tracheal stenosis. Ann Otol Rhinol Laryngol
115: 302–305, 2006.
52. Yu P, Clayman GL, Walsh GL: Human tracheal reconstruction with a composite radial forearm free flap and prosthesis. Ann Thorac Surg
81: 714–716, 2006.
53. Fairchild F: Reconstruction of the trachea. Surg Gynecol Obstet
44: 119–122, 1927.
54. Grillo HC, Dignan EF, Miura T: Experimental reconstruction of cervical trachea after circumferential resection. Surg Gynecol Obstet
122: 733–738, 1966.
55. Serrano A, Ortiz-Monasterio F, Andrade-Pradillo J: Reconstruction of the cervical trachea. Reconstruction of the cervical trachea. A technique to obtain a permanently patent airway. Plast Reconstr Surg
24: 333–340, 1959.
56. Papp C, McCraw JB, Arnold PG: Experimental reconstruction of the trachea with autogenous materials. J Thorac Cardiovasc Surg
90: 13–20, 1985.
57. Krespi YP, Biller HF, Baek SM: Tracheal reconstruction with a pleuroperiosteal flap. Otolaryngol Head Neck Surg
91: 610–614, 1983.
58. Kon M, van den Hooff A: Cartilage tube formation by perichondrium: a new concept for tracheal reconstruction. Plast Reconstr Surg
72: 791–797, 1983.
59. Cavadas PC: Tracheal reconstruction using a free jejunal flap with cartilage skeleton: Experimental study. Plast Reconstr Surg
101: 937–942, 1998.
60. Zhao F, Zhang Y, Liu S, Yu J: Artificial trachea reconstruction with two-stage approach using memory-alloy mesh. Chin Med J (Engl)
116: 1949–1951, 2003.
61. Botta Y, Meyer R: [Experimental reconstruction of the trachea with microsurgery (author's translation)]. Schweiz Rundsch Med Prax
67: 1588–1592, 1978.
62. Neville WE, Bolanowski PJ, Soltanzadeh H: Homograft replacement of the trachea using immunosuppression. J Thorac Cardiovasc Surg
72: 596–601, 1976.
63. Spinazzola AJ, Graziano JL, Neville WE: Experimental reconstruction of the tracheal carina. J Thorac Cardiovasc Surg
58: 1–13, 1969.
64. Condon W: Regeneration of tracheal and bronchial epithelium. J Thorac Surg
11: 333–346, 1941.
65. Pacheco CR, Rivero O, Porter JK: Experimental reconstructive surgery of the trachea. J Thorac Surg
27: 554–564, 1954.
66. Beigel A, Steffens-Knutzen R, Muller B, Schumacher U, Stein H: Tracheal transplantation. III. Demonstration of transplantation antigens on the tracheal mucosa of inbred rat strains. Arch Otorhinolaryngol
241: 1–8, 1984.
67. Bujia J, Wilmes E, Hammer C, Kastenbauer E: Tracheal transplantation: demonstration of HLA class II subregion gene products on human trachea. Acta Otolaryngol
110: 149–154, 1990.
68. Kalb TH, Chuang MT, Marom Z, Mayer L: Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol
4: 320–329, 1991.
69. Aronstam EM, Nims RM, Winn DF, Jr: Studies in segmental replacement of the thoracic trachea. J Thorac Cardiovasc Surg
1: 108–110, 1961.
70. Carter MG, Strieder JW: Resection of the trachea and bronchi: An experimental study. J Thorac Surg
20: 613–627; passim, 1950.
71. Greenberg SD: Tracheal homografts in dogs. AMA Arch Otolaryngol
67: 577–586, 1958.
72. Farrington WT, Hung WC, Binns PM: Experimental tracheal homografting. J Laryngol Otol
91: 101–110, 1977.
73. Alonso WA, Bridger GP, Bordley JE: Tracheal transplantation in dogs. Laryngoscope
82: 204–209, 1972.
74. Davies OG, Edmiston JM, Mc CH: The repair of experimental tracheal defects with fresh and preserved homologous tracheal grafts. J Thorac Surg
23: 367–376, 1952.
75. Messineo A, Filler RM, Bahoric A, Smith CR: Repair of long tracheal defects with cryopreserved cartilaginous allografts. J Pediatr Surg
27: 1131–1135, 1992.
76. Lenot B, Macchiarini P, Dulmet E, Weiss M, Dartevelle P: Tracheal allograft replacement. An unsuccessful method. Eur J Cardiothorac Surg
7: 648–652, 1993.
77. Jacobs JR: Investigations into tracheal prosthetic reconstruction. Laryngoscope
98: 1239–1245, 1988.
78. Hirata T, Yamazaki F, Fukuse T, et al
: Omentopexy for revascularization of free tracheal grafts in rats. Thorac Cardiovasc Surg
40: 178–181, 1992.
79. Nakanishi R, Shirakusa T, Takachi T: Omentopexy for tracheal autografts. Ann Thorac Surg
57: 841–845, 1994.
80. Fell SC, Mollenkopf FP, Montefusco CM, et al
: Revascularization of ischemic bronchial anastomoses by an intercostal pedicle flap. J Thorac Cardiovasc Surg
90: 172–178, 1985.
81. Li J, Xu P, Chen H, Yang Z, Zhang Q: Improvement of tracheal autograft survival with transplantation into the greater omentum. Ann Thorac Surg
60: 1592–1596, 1995.
82. Nakanishi R, Shirakusa T, Mitsudomi T: Maximum length of tracheal autografts in dogs. J Thorac Cardiovasc Surg
106: 1081–1087, 1993.
83. Balderman SC, Weinblatt G: Tracheal autograft revascularization. J Thorac Cardiovasc Surg
94: 434–441, 1987.
84. Yokomise H, Inui K, Wada H, Ueda M, Hitomi S: Long-term cryopreservation can prevent rejection of canine tracheal allografts with preservation of graft viability. J Thorac Cardiovasc Surg
111: 930–934, 1996.
85. Murai K, Oizumi H, Masaoka T, et al
: Removal of cartilage rings of the graft and omentopexy for extended tracheal autotransplantation. Ann Thorac Surg
67: 776–780, 1999.
86. Tojo T, Kitamura S, Gojo S, Kushibe K, Nezu K, Taniguchi S: Epithelial regeneration and preservation of tracheal cartilage after tracheal replacement with cryopreserved allograft in the rat. J Thorac Cardiovasc Surg
116: 624–627, 1998.
87. Mukaida T, Shimizu N, Aoe M, et al
: Experimental study of tracheal allotransplantation with cryopreserved grafts. J Thorac Cardiovasc Surg
116: 262–266, 1998.
88. Yokomise H, Inui K, Wada H, et al
: High-dose irradiation prevents rejection of canine tracheal allografts. J Thorac Cardiovasc Surg
107: 1391–1397, 1994.
89. Moriyama H, Sasajima T, Hirata S, Yamazaki K, Yatsuyanagi E, Kubo Y: Revascularization of canine cryopreserved tracheal allografts. Ann Thorac Surg
69: 1701–1706, 2000.
90. Inutsuka K, Kawahara K, Takachi T, Okabayashi K, Shiraishi T, Shirakusa T: Reconstruction of trachea and carina with immediate or cryopreserved allografts in dogs. Ann Thorac Surg
62: 1480–1484, 1996.
91. Khalil-Marzouk JF: Allograft replacement of the trachea. Experimental synchronous revascularization of composite thyrotracheal transplant. J Thorac Cardiovasc Surg
105: 242–246, 1993.
92. Daly RC, Tadjkarimi S, Khaghani A, Banner NR, Yacoub MH: Successful double-lung transplantation with direct bronchial artery revascularization. Ann Thorac Surg
56: 885–892, 1993.
93. Trendelenburg F: Beitraege zu den Operationen an den Luftwegen. Langenbecks Arch Chir
13: 335, 1872.
94. Carre P, Rousseau H, Lombart L, et al
: Balloon dilatation and self-expanding metal Wallstent insertion: For management of bronchostenosis following lung transplantation. The Toulouse Lung Transplantation Group. Chest
105: 343–348, 1994.
95. Montgomery WW: T-Tube tracheal stent. Arch Otolaryngol
82: 320–321, 1965.
96. Zwischenberger JB, Wittich GR, vanSonnenberg E, et al
: Airway simulation to guide stent placement for tracheobronchial obstruction in lung cancer. Ann Thorac Surg
64: 1619–1625, 1997.
97. Colt HG, Dumon JF: Airway stents. Present and future. Clin Chest Med
16: 465–478, 1995.
98. Saito Y, Imamura H: Airway stenting. Surg Today
35: 265–270, 2005.
99. Westaby S, Jackson JW, Pearson FG: A bifurcated silicone rubber stent for relief of tracheobronchial obstruction. J Thorac Cardiovasc Surg
83: 414–417, 1982.
100. Cooper JD, Pearson FG, Patterson GA, et al
: Use of silicone stents in the management of airway problems. Ann Thorac Surg
47: 371–378, 1989.
101. Dumon JF: A dedicated tracheobronchial stent. Chest
97: 328–332, 1990.
102. Dumon JC, S Diaz-Jimenez, JP Vergnon, JM Venuta, F Dumon, MC: Seven-year experience with the Dumon prosthesis. J Bronchol
3: 6–10, 1996.
103. Freitag L, Eicker R, Linz B, Greschuchna D: Theoretical and experimental basis for the development of a dynamic airway stent. Eur Respir J
7: 2038–2045, 1994.
104. Wood DE: Airway stenting. Chest Surg Clin N Am
11: 841–860, 2001.
105. Uchida BT, Putnam JS, Rosch J: Modifications of Gianturco expandable wire stents. AJR Am J Roentgenol
150: 1185–1187, 1988.
106. Zannini P, Melloni G, Chiesa G, Carretta A: Self-expanding stents in the treatment of tracheobronchial obstruction. Chest
106: 86–90, 1994.
107. Vinograd I, Klin B, Brosh T, Weinberg M, Flomenblit Y, Nevo Z: A new intratracheal stent made from nitinol, an alloy with “shape memory effect.” J Thorac Cardiovasc Surg
107: 1255–1261, 1994.
108. Madden BP, Datta S, Charokopos N: Experience with Ultraflex expandable metallic stents in the management of endobronchial pathology. Ann Thorac Surg
73: 938–944, 2002.
109. Bolliger CT: Airway stent. Semin Respir Crit Care Med
18: 563–570, 1997.
110. Backer CL, Mavroudis C, Gerber ME, Holinger LD: Tracheal surgery in children: An 18-year review of four techniques. Eur J Cardiothorac Surg
19: 777–784, 2001.
111. Dykes EH, Bahoric A, Smith C, Kent G, Filler RM: Reduced tracheal growth after reconstruction with pericardium. J Pediatr Surg
25: 25–29, 1990.
112. Tsugawa C, Nishijima E, Muraji T, et al
: The use of omental pedicle flap for tracheobronchial reconstruction in infants and children. J Pediatr Surg
26: 762–765, 1991.
113. Azorin JF, Bertin F, Martinod E, Laskar M: Tracheal replacement with an aortic autograft. Eur J Cardiothorac Surg
29: 261–263, 2006.
114. Pearson FG, Henderson RD, Gross AE, Ginsberg RJ, Stone RM: The reconstruction of circumferential tracheal defects with a porous prosthesis. An experimental and clinical study using heavy Marlex mesh. J Thorac Cardiovasc Surg
55: 605–616, 1968.
115. Penton RS, Brantigan OC: The use of a viable pedicle graft for repairing an extensive tracheobronchial defect. Ann Surg
135: 709–714, 1952.
116. Narodick BG, Pemberton AH, Worman LW: Tracheoplasty by means of a periosteal pedicle graft. J Thorac Cardiovasc Surg
47: 572–576, 1964.
117. Ross RR: Repair of tracheal and esophageal defect by use of a pedicle graft. Surgery
39: 654–662, 1956.
118. Delaere PR, Poorten VV, Goeleven A, Feron M, Hermans R: Tracheal autotransplantation: A reliable reconstructive technique for extended hemilaryngectomy defects. Laryngoscope
108: 929–934, 1998.
119. Hashizume K, Kanamori Y, Sugiyama M, Tomonaga T, Nakanishi H: Vascular-pedicled costal cartilage graft for the treatment of subglottic and upper tracheal stenosis. J Pediatr Surg
39: 1769–1771, 2004.
120. Teng MS, Malkin BD, Urken ML: Prefabricated composite free flaps for tracheal reconstruction: A new technique. Ann Otol Rhinol Laryngol
114: 822–826, 2005.
121. Olias J, Millan G, da Costa D: Circumferential tracheal reconstruction for the functional treatment of airway compromise. Laryngoscope
115: 159–161, 2005.
122. Nakahira M, Nakatani H, Takeuchi S, Higashiyama K, Fukushima K: Safe reconstruction of a large cervico-mediastinal tracheal defect with a pectoralis major myocutaneous flap and free costal cartilage grafts. Auris Nasus Larynx
33: 203–206, 2006.
123. Rose KG, Sesterhenn K, Wustrow F: Tracheal allotransplantation in man. Lancet
1: 433, 1979.
124. Levashov Yu N, Yablonsky PK, Cherny SM, Orlov SV, Shafirovsky BB, Kuznetzov IM: One-stage allotransplantation of thoracic segment of the trachea in a patient with idiopathic fibrosing mediastinitis and marked tracheal stenosis. Eur J Cardiothorac Surg
7: 383–386, 1993.
125. Klepetko W, Marta GM, Wisser W, et al
: Heterotopic tracheal transplantation with omentum wrapping in the abdominal position preserves functional and structural integrity of a human tracheal allograft. J Thorac Cardiovasc Surg
127: 862–867, 2004.
126. Wahidi MM, Ernst A: The Montgomery T-tube tracheal stent. Clin Chest Med
24: 437–443, 2003.
127. Puma F, Farabi R, Urbani M, et al
: Long-term safety and tolerance of silicone and self-expandable airway stents: an experimental study. Ann Thorac Surg
69: 1030–1034, 2000.
128. Freitag L, Tekolf E, Stamatis G, Greschuchna D: Clinical evaluation of a new bifurcated dynamic airway stent: A 5-year experience with 135 patients. Thorac Cardiovasc Surg
45: 6–12, 1997.
129. Filler RM, Forte V, Fraga JC, Matute J: The use of expandable metallic airway stents for tracheobronchial obstruction in children. J Pediatr Surg 30: 1050–1055; discussion 1055–1056, 1995.
130. Shaffer JP, Allen JN: The use of expandable metal stents to facilitate extubation in patients with large airway obstruction. Chest
114: 1378–1382, 1998.
131. Susanto I, Peters JI, Levine SM, Sako EY, Anzueto A, Bryan CL: Use of balloon-expandable metallic stents in the management of bronchial stenosis and bronchomalacia after lung transplantation. Chest
114: 1330–1335, 1998.
132. Rousseau H, Dahan M, Lauque D, et al: Self-expandable prostheses in the tracheobronchial tree. Radiology 188: 199–203, 1993.
133. Bolliger CT, Breitenbuecher A, Brutsche M, Heitz M, Stanzel F: Use of studded Polyflex stents in patients with neoplastic obstructions of the central airways. Respiration
71: 83–87, 2004.
Copyright © 2007 by the American Society for Artificial Internal Organs
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Data is temporarily unavailable. Please try again soon.